Nivolumab
Nivolumab anti-PD-1) is a genetically engineered fully human immunoglobulin Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1PD-1PCD-1) with immune checkpoint inhibitory and antineoplastic activities.
Product Specifications
CAS Number
946414-94-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
146 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
PD-1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP75104_P050 100 µL
SALL2 Antibody - middle region (ARP75104_P050)
Sign In for Pricing
View Details 
K0958206 1.0 µg DNA
HIST1H3E sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details